← Back to headlines
Moderna Stock Rises After Legal Battle Resolution
Moderna's stock climbed 16% following the resolution of its legal dispute with Arbutus-Genevant, clearing a significant hurdle for the pharmaceutical company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
